← Back to Search

Motivational and Cognitive Intervention for Heavy Drinking in College Students (MCID Trial)

Phase 1
Waitlist Available
Led By Giao Q. Tran, Ph.D.
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Must not have
Current suicidal ideation
Current hallucinations
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new intervention for college students who drink heavily to cope with anxiety and depression, which can lead to alcohol dependence.

Who is the study for?
This trial is for college students who often drink heavily, partly to deal with anxiety and depression. They should have had at least one heavy drinking episode recently but shouldn't be severely alcohol dependent or have a serious mental health diagnosis like hallucinations or suicidal thoughts.
What is being tested?
The study is testing two approaches: Brief Motivational Intervention (BMI) and the new Motivational and Cognitive Intervention for Drinkers (MCID). These are designed to help students who drink due to stress, anxiety, or sadness.
What are the potential side effects?
Since this trial involves counseling interventions rather than medications, there may not be typical 'side effects.' Participants might experience discomfort discussing personal issues related to drinking, anxiety, or depression.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently having thoughts about harming myself.
Select...
I am experiencing hallucinations.
Select...
I have a diagnosed mental health condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: MCIDExperimental Treatment1 Intervention
Group II: BMIExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brief Motivational Intervention (BMI)
2012
N/A
~1190

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
837 Previous Clinical Trials
1,082,934 Total Patients Enrolled
26 Trials studying Depression
8,076 Patients Enrolled for Depression
University of CincinnatiLead Sponsor
438 Previous Clinical Trials
638,588 Total Patients Enrolled
22 Trials studying Depression
3,246 Patients Enrolled for Depression
Giao Q. Tran, Ph.D.Principal InvestigatorUniversity of Cincinnati
1 Previous Clinical Trials
53 Total Patients Enrolled

Media Library

Brief Motivational Intervention (BMI) Clinical Trial Eligibility Overview. Trial Name: NCT01204229 — Phase 1
Depression Research Study Groups: BMI, MCID
Depression Clinical Trial 2023: Brief Motivational Intervention (BMI) Highlights & Side Effects. Trial Name: NCT01204229 — Phase 1
Brief Motivational Intervention (BMI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01204229 — Phase 1
~6 spots leftby Dec 2025